Autism Spectrum Disorder
📧 Sign up to get email alerts when something new happens for Autism Spectrum Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-12-01FDA Approved: RISPERDAL — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for risperidone (RISPERDAL) from Janssen Pharmaceuticals, Inc., resulting in changes to its labe…
-
FDA label_change · 2010-12-01FDA Approved: ABILIFY — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
The FDA approved a supplemental application for ABILIFY (aripiprazole) submitted by Otsuka America Pharmaceutical, Inc., resulting in change…
-
CLINICAL_TRIALS research · 2010-10-29Clinical Trial Update: Pain and Emotional Expression in Children With Autism or Mental Retardation
This document provides an update on a clinical trial studying pain perception and emotional expression in children with autism and intellect…
-
CLINICAL_TRIALS trial_result · 2010-10-28Clinical Trial Update: My Scrivener® - Measuring Effectiveness and Dose Response in Children [Phase 1, Phase 2]
This document reports a completed Phase 1/Phase 2 trial of My Scrivener in children, evaluating effectiveness and dose response. The study e…
-
CLINICAL_TRIALS trial_result · 2010-10-20Clinical Trial Update: Vitamin/Mineral Supplement for Children and Adults With Autism [Phase 2]
Phase 2 clinical trial evaluating a vitamin/mineral supplement in children and adults with autism has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2010-10-05Clinical Trial Update: Collaborative Study Of Neurofeedback Training Of 6-18 Year Olds With Autism [Phase 1]
A Phase 1 clinical trial evaluating neurofeedback training in children aged 6 to 18 with autism.
-
CLINICAL_TRIALS trial_result · 2010-10-01Clinical Trial Update: ScanBrit Dietary Intervention in Autism [Phase 2]
Phase 2 results for the ScanBrit dietary intervention in autism have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2010-09-28Clinical Trial Update: A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder [Phase 4]
Phase 4 trial evaluating two doses of risperidone for safety and effectiveness in children and adolescents with autism spectrum disorder; th…
-
FDA approval · 2010-08-30FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Risperdal M-TAB (risperidone) from Janssen Pharmaceuticals, expanding or updating its formulatio…
-
CLINICAL_TRIALS trial_result · 2010-08-24Clinical Trial Update: Cognitive-Behavioral Therapy for Children With High-Functioning Autism Spectrum Disorder and Anxiety [Phase 1]
Phase 1 trial evaluating cognitive-behavioral therapy for children with high-functioning autism spectrum disorder and anxiety has completed.
-
CLINICAL_TRIALS research · 2010-08-24Clinical Trial Update: Evaluating PEGASUS - a Group Intervention for Young People With an Autism Spectrum Disorder [NA]
This clinical trial update notes the evaluation of PEGASUS, a group intervention for young people with autism spectrum disorder, but the stu…
-
FDA approval · 2010-08-06FDA Approved: RISPERIDONE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical's generic risperidone (ANDA) for the same indications as the brand-label. The approval covers schizophrenia,…
-
FDA approval · 2010-08-06FDA Approved: RISPERIDONE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries, Inc.'s original ANDA for risperidone, providing a generic version of this antipsychotic.
-
CLINICAL_TRIALS trial_result · 2010-07-26Clinical Trial Update: A Study of a Developmental,Individual-Difference,Relationship-Bases/Floortime Intervention for Children With Autistic [NA]
This clinical trial update indicates that a Floortime intervention study for children with autism spectrum disorder has completed.
-
FDA approval · 2010-06-29FDA Approved: RISPERIDONE — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved Torrent Pharmaceuticals Limited's supplemental application for risperidone, updating the labeling for this generic product.
-
CLINICAL_TRIALS trial_result · 2010-06-17Clinical Trial Update: Ziprasidone in Children With Autism: A Pilot Study [Phase 2]
A Phase 2 pilot trial evaluating ziprasidone in children with autism has completed.
-
CLINICAL_TRIALS research · 2010-05-04Clinical Trial Update: EEG Studies of Sensory Processing in Autistic Children
Clinical trial update describing EEG studies of sensory processing in children with autism, sponsored by Massachusetts General Hospital.
-
FDA approval · 2010-04-27FDA Approved: RISPERIDONE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for risperidone from ANI Pharmaceuticals, Inc., under an ANDA.
-
CLINICAL_TRIALS research · 2010-04-02Clinical Trial Update: Developmental Delay in Children Exposed During Pregnancy to Either Lamotrigine,Sodium Valproate, or Carbamazepine
This clinical trial update describes developmental outcomes in children exposed in utero to lamotrigine, sodium valproate, or carbamazepine,…
-
CLINICAL_TRIALS trial_result · 2010-03-25Clinical Trial Update: An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications. [Phase 4]
This update notes the completion of an open-label Phase 4 trial evaluating metformin for weight control in pediatric patients on antipsychot…
-
CLINICAL_TRIALS other · 2010-02-23Clinical Trial Update: Extended Management and Measurement of Autism [Phase 3]
This Phase 3 trial evaluating extended management and measurement of autism, sponsored by Neuropharm, has been terminated.
-
FDA approval · 2010-02-19FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals, LLC's supplemental application for risperidone (ANDA 078707). This action represents an approval r…
-
CLINICAL_TRIALS trial_result · 2010-01-25Clinical Trial Update: Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD) [Phase 3]
Phase 3 clinical trial update for aripiprazole in treating serious behavioral problems in children and adolescents with autism. The study ha…
-
FDA approval · 2010-01-12FDA Approved: RISPERIDONE — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for risperidone filed by Zydus Lifesciences Limited, granting approval for a generic version und…
-
FDA approval · 2009-12-15FDA Approved: RISPERIDONE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for risperidone from ANI Pharmaceuticals, Inc., resulting in a generic risperidone product being…